Cargando…

Clinical and microbiological evaluation of temocillin for bloodstream infections with Enterobacterales: a Belgian single-centre retrospective study

BACKGROUND: Expanding the use of temocillin could be an important weapon in the fight against antimicrobial resistance. However, EUCAST defined clinical breakpoints for a limited number of species and only for urinary tract infections (UTI), including urosepsis but excluding severe sepsis and septic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oosterbos, Julie, Schalkwijk, Maaike, Thiessen, Steven, Oris, Els, Coppens, Guy, Lagrou, Katrien, Steensels, Deborah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397121/ https://www.ncbi.nlm.nih.gov/pubmed/36003075 http://dx.doi.org/10.1093/jacamr/dlac086

Ejemplares similares

Rapid detection of temocillin resistance in Enterobacterales
por: Findlay, Jacqueline, et al.
Publicado: (2023)

Impact of revised breakpoints on the categorization of susceptibility of Enterobacterales to temocillin
por: Farfour, Eric, et al.
Publicado: (2023)

Clinical outcomes of temocillin use for invasive Enterobacterales infections: a single-centre retrospective analysis
por: Heard, Katie L, et al.
Publicado: (2021)

In vitro activity of mecillinam, temocillin and nitroxoline against MDR Enterobacterales
por: Plambeck, Lars, et al.
Publicado: (2022)

Activity of temocillin against ESBL-, AmpC-, and/or KPC-producing Enterobacterales isolated in Poland
por: Kuch, Alicja, et al.
Publicado: (2020)

Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a randomised, pragmatic trial
por: Marín-Candón, Alicia, et al.
Publicado: (2021)

Clinical, microbiological characteristics and predictors of mortality in patients with carbapenemase-producing Enterobacterales bloodstream infections: a multicentre study
por: Anton-Vazquez, Vanesa, et al.
Publicado: (2023)

Activity of temocillin against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae bloodstream isolates from a clinical trial
por: Stewart, Adam G, et al.
Publicado: (2021)

Real-life temocillin use in Greater Paris area, effectiveness and risk factors for failure in infections caused by ESBL-producing Enterobacterales: a multicentre retrospective study
por: Dinh, Aurélien, et al.
Publicado: (2022)

Towards Multitarget Testing in Molecular Microbiology
por: Steensels, Deborah, et al.
Publicado: (2013)

128 days of SARS-CoV-2 viral shedding in a haemodialysis patient
por: Heylen, Line, et al.
Publicado: (2021)

Correction to: Real-life temocillin use in Greater Paris area, effectiveness and risk factors for failure in infections caused by ESBL-producing Enterobacterales: a multicentre retrospective study
Publicado: (2023)

Continuous versus intermittent infusion of temocillin in intensive care unit patients
por: Claeysoone, K, et al.
Publicado: (2005)

Temocillin: Applications in Antimicrobial Stewardship as a Potential Carbapenem-Sparing Antibiotic
por: Lupia, Tommaso, et al.
Publicado: (2022)

The future of integrated primary care: community health centres at the heart of the neighbourhood
por: van Oosterbos, Han
Publicado: (2006)

Clinical Efficacy of Temocillin Standard Dosing in Patients Treated with Outpatient Antimicrobial Therapy
por: Van den Broucke, Evelyne, et al.
Publicado: (2022)

Empirical use of temocillin in hospitalized patients: results from a retrospective audit
por: Kandil, Hala, et al.
Publicado: (2023)

Laboratory information system requirements to manage the COVID-19 pandemic: A report from the Belgian national reference testing center
por: Weemaes, Matthias, et al.
Publicado: (2020)

Pulmonary Aspergillosis in Humboldt Penguins—Susceptibility Patterns and Molecular Epidemiology of Clinical and Environmental Aspergillus fumigatus Isolates from a Belgian Zoo, 2017–2022
por: Debergh, Hanne, et al.
Publicado: (2023)

Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales
por: Ávila-Núñez, M., et al.
Publicado: (2023)

Bloodstream Infections by AmpC-Producing Enterobacterales: Risk Factors and Therapeutic Outcome
por: Pospišil, Mladen, et al.
Publicado: (2023)

1029. Increased Mortality in Hospital-Onset Carbapenem-Resistant Enterobacterales Bloodstream Infections
por: Boutzoukas, Angelique E, et al.
Publicado: (2023)

Correction to: Empirical use of temocillin in hospitalized patients: results from a retrospective audit
Publicado: (2023)

By Belgians for Belgians
por: Childers, M. A.
Publicado: (1915)

Belgian National Survey on Tinea Capitis: Epidemiological Considerations and Highlight of Terbinafine-Resistant T. mentagrophytes with a Mutation on SQLE Gene
por: Sacheli, Rosalie, et al.
Publicado: (2020)

Antibiotic Susceptibility, Virulome, and Clinical Outcomes in European Infants with Bloodstream Infections Caused by Enterobacterales
por: Folgori, Laura, et al.
Publicado: (2021)

Activity of temocillin and 15 other agents, including fosfomycin and colistin, against Enterobacteriaceae in Hong Kong
por: Ip, Margaret, et al.
Publicado: (2017)

Cost-Effectiveness Analysis of Temocillin Treatment in Patients with Febrile UTI Accounting for the Emergence of Antibiotic Resistance
por: Larsson, Sofie, et al.
Publicado: (2022)

Optimization of Empirical Antimicrobial Therapy in Enterobacterales Bloodstream Infection Using the Extended-Spectrum Beta-Lactamase Prediction Score
por: Haimerl, Brian J., et al.
Publicado: (2023)

The genetic structure of the Belgian population
por: Van den Eynden, Jimmy, et al.
Publicado: (2018)

Antimicrobial Resistance in Enterobacterales Bacilli Isolated from Bloodstream Infection in Surgical Patients of Polish Hospitals
por: Kłos, M., et al.
Publicado: (2021)

Susceptibility of Escherichia coli from Community-Acquired Urinary Tract Infection to Fosfomycin, Nitrofurantoin, and Temocillin in Korea
por: Seo, Mi-Ran, et al.
Publicado: (2014)

Evolution of micro-organisms isolated in nosocomial bloodstream infections in Belgian Intensive Care Units, 1992-1999
por: Jans, B, et al.
Publicado: (2000)

313. Using a Clinical Decision Prediction Tool to Improve Empirical Antimicrobial Therapy in Ceftriaxone-Resistant Enterobacterales Bloodstream Infections
por: McDougal, Elizabeth, et al.
Publicado: (2020)

1014. Microbiology and Outcome of Bloodstream Infections in Children With Intestinal Failure
por: Seddik, Talal, et al.
Publicado: (2018)

Budget impact analysis of temocillin insurance coverage for urinary tract infections caused by ESBL-producing pathogens in Iran
por: Seyedifar, Meysam, et al.
Publicado: (2023)

Blood culture surveillance in a secondary care hospital in Benin: epidemiology of bloodstream infection pathogens and antimicrobial resistance
por: Ombelet, Sien, et al.
Publicado: (2022)

Trends in Belgian cause-specific mortality by migrant origin between the 1990s and the 2000s
por: Vanthomme, Katrien, et al.
Publicado: (2019)

Sustainable employability for older workers: an explorative survey of belgian companies
por: Verbrugghe, Mathieu, et al.
Publicado: (2016)

Risk Factors of Death in Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacterales in Patients with Neoplasia
por: da Cunha Ferreira, Tiago, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bv4i8sn6pk4e8es6v6u35f6j6s